openPR Logo
Press release

Small Interfering RNA (siRNA) Therapeutics Market 2021- Key Strategy, Revenue, Opportunity, Business Segment Overview and Key Trends -2028 | Horizon Discovery, GlaxoSmithKline, Sirna Therapeutics, Inc., Alnylam Pharmaceuticals & More

09-15-2021 06:12 PM CET | Health & Medicine

Press release from: The Insight Partners

Small Interfering RNA (siRNA) Therapeutics Market

Small Interfering RNA (siRNA) Therapeutics Market

Worldwide Small Interfering RNA (siRNA) Therapeutics Market Analysis to 2028 is a specialized and in-depth study of the Small Interfering RNA (siRNA) Therapeutics Market Industry with a focus on the global market trend. The report aims to provide an overview of global Small Interfering RNA (siRNA) Therapeutics Market with detailed market segmentation by product/application and geography. The global Small Interfering RNA (siRNA) Therapeutics Market is expected to witness high growth during the forecast period. The report provides key statistics on the Market status of the players and offers key trends and opportunities in the market.

Research report has been compiled by studying the market in-depth along with drivers, opportunities, restraints & other strategies as well as new-developments that can help a reader to understand the exact situation of the market along with the factors that can limit or hamper the market growth and the report also has been updated with Impacts & effects of Coronavirus pandemic and how it has influenced consumer behavior& the growth of the market as well as industries.

Avail Sample PDF Copy of this Report @ https://bit.ly/3nxDqBn

This report focuses on the global Small Interfering RNA (siRNA) Therapeutics Market with the future forecast, growth opportunity, key market, and key players. The study objectives are to present the Small Interfering RNA (siRNA) Therapeutics Market development in North America, Europe, China, Japan, Southeast Asia, India, and Central & South America.

What’s included :

• Market Dynamics
• Competitive Analysis
• Market Trends And Market Outlook
• Market Share And Market Size
• Opportunities And Customer Analysis
• Product Pricing Research

Leading Key Players in Small Interfering RNA (siRNA) Therapeutics Market:

Horizon Discovery, GlaxoSmithKline, Sirna Therapeutics, Inc., Alnylam Pharmaceuticals, Sanofi Genzyme, Olix Pharmaceuticals, Silence Therapeutics AG, Calando Pharmaceuticals, Arbutus Biopharma Corp, Sylentis S.A

MARKET SEGMENTATION

• Based on indication, the global small interfering RNA (siRNA) therapeutics market is segmented into oncology, cardiovascular diseases, respiratory disorders, neurodegenerative disorders, infectious diseases and other.
• Based on types, the market is segmented into liposome based systemic therapy, nanoparticle based systemic therapy and other.
• On the basis of end-users, the market is bifurcated into diagnostic laboratory, research and academic laboratories.

The Small Interfering RNA (siRNA) Therapeutics Market is anticipated to grow with a significant rate in the coming years, owing to factors such as, rising incidence and prevalence of chronic diseases, increasing healthcare expenses toward growth of eHealth, telemedicine, telehealth. Rapid growth in delivery of services to patients, several technological enlargements in the healthcare industry in Asia Pacific and Europe are expected to offer growth opportunities for the players operating in the market.

The report offers key drivers that propel the growth in the global Small Interfering RNA (siRNA) Therapeutics Market. These insights help market players in devising strategies to gain market presence. The research also outlined the restraints of the market. Insights on opportunities are mentioned to assist market players in taking further steps by determining the potential in untapped regions.

Interested in purchasing this Report? Click here @
https://bit.ly/3keKKjm

Reason to Buy :
• Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Small Interfering RNA (siRNA) Therapeutics Market.
• Highlights key business priorities in order to guide the companies to reform their business strategies and establish themselves in the wide geography.
• The key findings and recommendations highlight crucial progressive industry trends in the Small Interfering RNA (siRNA) Therapeutics Market, thereby allowing players to develop effective long term strategies in order to garner their market revenue.
• Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
• Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those restraining the growth at a certain extent.
• Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to products, segmentation and industry verticals.

Contact US
Contact Person : Sameer Joshi
Phone : +1-646-491-9876
E-mail : sales@theinsightpartners.com

About US

The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Food and Beverages, Consumers and Goods, Chemicals and Materials.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Small Interfering RNA (siRNA) Therapeutics Market 2021- Key Strategy, Revenue, Opportunity, Business Segment Overview and Key Trends -2028 | Horizon Discovery, GlaxoSmithKline, Sirna Therapeutics, Inc., Alnylam Pharmaceuticals & More here

News-ID: 2394743 • Views:

More Releases from The Insight Partners

Whole Exome Sequencing - Obtain Ultimate PDF Guide
Whole exome sequencing is the next-generation technique that is widely preferred as a substitute for whole genome sequencing due to its advantages. As the whole sequencing technique reduces the time and cost of analyzing genetics, it also offers a reduction of time spent in the trial and error for the drug formulation. The next-generation sequencing has enabled higher results of the analysis for genotypic and phenotypic relations among the human
Neurophotonics Market Analysis, Size, Share, Growth Drivers, and Trends 2031
The Global Neurophotonics Market 2031 that centers around Neurophotonics Market examines the significant components with a top to bottom methodology and empowers the client to survey the drawn-out based interest additionally predicts explicit executions. This report gives subjective investigation, clarifying item scope and expounding Market experiences and standpoint. To Get Sample Copy of Report, Click Here - https://www.theinsightpartners.com/sample/TIPRE00040006/?utm_source=OpenPR&utm_medium=10607 (Our SAMPLE COPY of the report offers a quick advent to
Dacarbazine Market Gains Momentum with Strategic Acquisitions
Dacarbazine Market Gains Momentum with Strategic Acquisitions
New York, US - September 05, 2025 - The Insight Partners today announced the publication of its latest Dacarbazine Market report titled "Dacarbazine Market Share, Size, Trends, and Forecast by 2031," which anticipates steady expansion in the global oncology pharmaceutical market. The report sheds light on how ongoing cancer research, biosimilar development, and strategic manufacturing initiatives are significantly influencing the Dacarbazine Market size and driving competitive Dacarbazine Market share among
Rising Demand for Neurosurgical Devices Drives Strong Market Outlook for Ultrasonic Aspirators
Rising Demand for Neurosurgical Devices Drives Strong Market Outlook for Ultraso …
New York, US - September 8, 2025 - According to a new report from The Insight Partners, the Neurology Ultrasonic Aspirators Market is poised for strong expansion. The report projects that the market's growth is being fueled by an increasing global prevalence of neurological disorders, the rising popularity of minimally invasive surgical techniques, and continuous technological advancements. Download Sample PDF @ https://www.theinsightpartners.com/sample/TIPRE00006973/?utm_source=OpenPR&utm_medium=10759 Key Trends Shaping the Neurology Ultrasonic Aspirators Market The market

All 5 Releases


More Releases for RNA

CD Formulation Launches Custom Circular RNA Synthesis Service to Accelerate RNA …
CD Formulation introduces a customizable circRNA synthesis service, delivering high-quality, stable circRNAs for therapeutics, vaccines, and gene research, supported by advanced design and QC processes. CD Formulation, a leading provider of advanced small nucleic acid synthesis [https://www.formulationbio.com/nucleic-acid/custom-small-nucleic-acid-synthesis.html] solutions, is proud to announce the launch of its fully customizable circular RNA (circRNA) synthesis service. This new service addresses the growing need for stable, non-immunogenic RNA molecules for therapeutic development, vaccine research, and
Self-Amplifying RNA Synthesis Market Gains Traction as Biotech Firms Embrace Sca …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the " Self-Amplifying RNA Synthesis Market- (By Product & Service (Products (Enzymes & Reagents, Premade saRNA, Others), Custom Synthesis Services), By Application (Therapeutics Development (Oncology, Infectious Diseases, Others), Biomedical Research), By End-User (Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Others)), Trends, Industry Competition Analysis, Revenue and Forecast To 2034." According to the latest research by InsightAce Analytic,
RNA Extraction and RNA Purification Market: Growth, Trends & Competitive Landsca …
The global RNA Extraction and RNA Purification Market is expected to grow at 6.3% CAGR from 2025 to 2032. This Market Report is the result of extensive research and analysis conducted by our team of experienced market researchers through - • 70% efforts of Primary Research • 15% efforts of Secondary Research • 15% efforts from the subscription to Paid database providing industry overview, macro and micro economics factors, and financials of private limited
RNA Targeting Small Molecules Therapeutics Market: Exponential Growth with Risin …
Estimations Predict a CAGR of 29.8% by 2029 in Global RNA Targeting Small Molecules Therapeutics Market Boosted by Precision Medicine, RNA Biomarker Identification and RNA Genetic Manipulation What Is The Projected Market Size of The Global RNA Targeting Small Molecules Therapeutics Market And Its Growth Rate? • The market will grow from $6.1 billion in 2024 to $7.87 billion in 2025 at a compound annual growth rate (CAGR) of 28.9%. • Expected exponential
Global DNARNA Extraction Kit Market by Type (Cell-free DNA (cfDNA), Sequence-spe …
"DNARNA Extraction Kit Market" is segmented by Company, Region (country), By Type, Application, stakeholders and other participants. This report provides an analysis of revenue and forecast across Type and Application segments for 2023-2032. The market for DNARNA Extraction Kits has been thoroughly researched via primary and secondary sources to produce this research study. Along with a competitive analysis of the market, segmented by application, type, and geographical trends, it offers a
Cancer RNA Expression Market to Reap Excessive Revenues by 2028(By sequencing te …
Worldwide cancer is one of the leading cause of death and effective way of treating it still looks unaccomplished in most parts of the world. The factors which influence the successful treatment of cancer are different depending on the stage of diagnosis, treatment availability and availability of trained healthcare professionals coupled with high economic burden of the disease. The gene expression of cancerous cells varies by cancer type and may